MedPage Today on MSN
Practice-Influencing Results in Oligometastatic Prostate Cancer
Median progression-free survival (PFS) increased from 7.4 months with stereotactic body radiotherapy (SBRT) to 17.6 months with the addition of 177 lutetium (Lu) PNT2002 targeting prostate-specific ...
The 2025 ASTRO annual meeting featured a clinical trials session and a presentation by Dr. Amar Kishan discussing the primary ...
In a recent annual report from the American Cancer Society, it said the statistics for prostate cancer is rising after the ...
Until about 15 years ago, most men diagnosed with prostate cancer — no matter how aggressive — underwent surgery or radiation ...
September is Prostate Cancer Awareness Month, and when many men choose to get check-ups. Though the month is nearly over, ...
Some avid watchers of football broadcasts have no doubt become aware of a drug called Pluvicto. That’s because commercials ...
Patients with prostate cancer can position themselves to receive the best care possible by being seen by a multidisciplinary ...
Eric Morrow is no stranger to unexpected journeys. News4 caught up with the prostate cancer survivor and Air Force veteran as he headed off on a lifechanging trip. “I wouldn’t wish cancer on anyone, ...
The Health Minister says New Zealand's first Advanced Practitioner Radiation Therapist specialised in prostate cancer, is transforming care in the region. The practitioner runs review clinics, ...
The travel writer and host of 'Rick Steves Europe' shares an update after prostate cancer diagnosis to encourage men to 'say ...
Prostate cancer is one of the most common cancers in men. About one in eight men will be diagnosed with prostate cancer ...
Doctors explain how to protect yourself against prostate cancer, common symptoms of prostate cancer, when to get screened, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results